The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study.
about
Clinical outcomes in psoriatic arthritis: A systematic literature reviewTumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literatureEfficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics RegisterLarge-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review.Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies.Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007Methotrexate Efficacy in the Tight Control in Psoriatic Arthritis Study.Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics RegisterThe impact of a revised EQ-5D population scoring on preference-based utility scores in an inflammatory arthritis cohortDrug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis.Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), ChecTherapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.Ustekinumab for the treatment of psoriatic arthritis.Register-Based Evaluation of Relative Effectiveness of New Therapies: Biologics Versus Conventional Agents in Treatment of Psoriasis in Sweden.Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA.Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.Leflunomide in psoriatic arthritis: results from a large European prospective observational study.Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry.The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registry.
P2860
Q26995307-89B275F9-8169-4014-BD48-7D9B2EE49971Q27012134-03EA5B7D-8BFF-466E-A5E2-533B7CDDE227Q33726924-60A3BF0F-6A88-4769-891C-6B00A9CC37C4Q33858767-B4D55CCB-6766-4874-BDCC-BBDF08DFA299Q34017619-106426E2-CF98-452B-BF9C-66389DDDFBEDQ34023923-6B959383-86AC-42C5-AD19-B7D392440489Q36171750-480009CA-3AFC-4A51-8667-44B203CCCE59Q36542790-EAA18562-A5CC-44AC-BAA4-001F4C338198Q37206976-FF408645-78B0-41B2-A8A0-ADF4D0DCC33BQ37265106-14D99A04-5515-4694-8715-A0848CBDEA32Q37826195-A78E9071-2DBB-4FA7-B90A-283E45494754Q38010362-1CBE3975-1339-43C7-8773-A5F8B9202539Q38098466-57EC1E14-55BA-4088-855F-85709DE800A0Q38177336-93D93499-35C1-4CAB-8DDA-ACAE90DC70BEQ40209526-F79AE585-3F12-4833-B47B-817A2C67CB54Q41615511-E961EC64-4FE7-49D5-A2A8-556E1163DD02Q42210089-CAFFE09F-7E3D-4C42-9A71-5F4F272AE3C8Q43673954-16ACA9A9-8A01-401C-8520-BD6755D46730Q50553120-7DA64E8F-AA28-47F5-9260-E5D1208B7486Q54998113-5B9437B5-7C87-4AE4-8B7E-C3F880FE8052
P2860
The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The comparative effectiveness ...... ervational, multicentre study.
@ast
The comparative effectiveness ...... ervational, multicentre study.
@en
type
label
The comparative effectiveness ...... ervational, multicentre study.
@ast
The comparative effectiveness ...... ervational, multicentre study.
@en
prefLabel
The comparative effectiveness ...... ervational, multicentre study.
@ast
The comparative effectiveness ...... ervational, multicentre study.
@en
P2093
P2860
P356
P1476
The comparative effectiveness ...... ervational, multicentre study.
@en
P2093
C Kaufmann
E Rødevand
K Mikkelsen
M S Heiberg
P Mowinckel
W Koldingsnes
P2860
P304
P356
10.1136/ARD.2006.064808
P407
P577
2007-01-09T00:00:00Z